Search research articles
Contact Us
Filters
Showing results (351-360 of 360) with videos related to
Page
of 36
Sort By:
You have reached the last page of results.
This site can display upto 360 results.
The Journal of Biological Chemistry
|
September 26, 2008
CHP2 activates the calcineurin/nuclear factor of activated T cells signaling pathway and enhances the oncogenic potential of HEK293 cells
Guo-Dong Li, Xi Zhang, Rong Li, et al.
British Journal of Pharmacology
|
October 28, 2010
Biological actions of green tea catechins on cardiac troponin C
Naoto Tadano, Cheng-Kun Du, Fumiaki Yumoto, et al.
Oncotarget
|
April 14, 2017
Tumor and serum gamma-glutamyl transpeptidase, new prognostic and molecular interpretation of an old biomarker in gastric cancer
Qinchuan Wang, Xiang Shu, Yong Dong, et al.
Cell Chemical Biology
|
July 12, 2023
Integrating inflammatory biomarker analysis and artificial-intelligence-enabled image-based profiling to identify drug targets for intestinal fibrosis
Shan Yu, Alexandr A Kalinin, Maria D Paraskevopoulou, et al.
Journal of Cellular and Molecular Medicine
|
June 12, 2021
PLAC8 promotes adriamycin resistance via blocking autophagy in breast cancer
Yongxia Chen, Yunlu Jia, Misha Mao, et al.
Circulation Research
|
June 9, 2007
Knock-in mouse model of dilated cardiomyopathy caused by troponin mutation
Cheng-Kun Du, Sachio Morimoto, Kiyomasa Nishii, et al.
Chemistry & Biology
|
September 15, 2015
KDM4/JMJD2 Histone Demethylase Inhibitors Block Prostate Tumor Growth by Suppressing the Expression of AR and BMYB-Regulated Genes
Lingling Duan, Ganesha Rai, Carlos Roggero, et al.
Frontiers in Oncology
|
March 31, 2022
Corrigendum: STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1
Zhaoqing Li, Cong Chen, Lini Chen, et al.
Frontiers in Oncology
|
August 2, 2021
STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1
Zhaoqing Li, Cong Chen, Lini Chen, et al.
International Immunopharmacology
|
November 5, 2023
Association of hepatitis B virus DNA levels with efficacy and safety outcomes in patients with hepatitis B virus-associated advanced hepatocellular carcinoma receiving tyrosine kinase inhibitor plus anti-PD-1 antibody: a multicenter propensity-matched study
Qing-Jing Chen, Kong-Ying Lin, Zhi-Wen Lin, et al.
Page
of 36
Search research articles
Search
Showing results (351-360 of 360) with videos related to
Sort By:
Page
of 36
You have reached the last page of results.
This site can display upto 360 results.
The Journal of Biological Chemistry
|
September 26, 2008
CHP2 activates the calcineurin/nuclear factor of activated T cells signaling pathway and enhances the oncogenic potential of HEK293 cells
Guo-Dong Li, Xi Zhang, Rong Li, et al.
British Journal of Pharmacology
|
October 28, 2010
Biological actions of green tea catechins on cardiac troponin C
Naoto Tadano, Cheng-Kun Du, Fumiaki Yumoto, et al.
Oncotarget
|
April 14, 2017
Tumor and serum gamma-glutamyl transpeptidase, new prognostic and molecular interpretation of an old biomarker in gastric cancer
Qinchuan Wang, Xiang Shu, Yong Dong, et al.
Cell Chemical Biology
|
July 12, 2023
Integrating inflammatory biomarker analysis and artificial-intelligence-enabled image-based profiling to identify drug targets for intestinal fibrosis
Shan Yu, Alexandr A Kalinin, Maria D Paraskevopoulou, et al.
Journal of Cellular and Molecular Medicine
|
June 12, 2021
PLAC8 promotes adriamycin resistance via blocking autophagy in breast cancer
Yongxia Chen, Yunlu Jia, Misha Mao, et al.
Circulation Research
|
June 9, 2007
Knock-in mouse model of dilated cardiomyopathy caused by troponin mutation
Cheng-Kun Du, Sachio Morimoto, Kiyomasa Nishii, et al.
Chemistry & Biology
|
September 15, 2015
KDM4/JMJD2 Histone Demethylase Inhibitors Block Prostate Tumor Growth by Suppressing the Expression of AR and BMYB-Regulated Genes
Lingling Duan, Ganesha Rai, Carlos Roggero, et al.
Frontiers in Oncology
|
March 31, 2022
Corrigendum: STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1
Zhaoqing Li, Cong Chen, Lini Chen, et al.
Frontiers in Oncology
|
August 2, 2021
STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1
Zhaoqing Li, Cong Chen, Lini Chen, et al.
International Immunopharmacology
|
November 5, 2023
Association of hepatitis B virus DNA levels with efficacy and safety outcomes in patients with hepatitis B virus-associated advanced hepatocellular carcinoma receiving tyrosine kinase inhibitor plus anti-PD-1 antibody: a multicenter propensity-matched study
Qing-Jing Chen, Kong-Ying Lin, Zhi-Wen Lin, et al.
Page
of 36